U.S. drug overdose deaths have fallen to their lowest level in roughly a decade, according to Centers for Disease Control and Prevention data discussed in a November 18, 2026, report. The White House said the decline represents nearly 50,000 fewer deaths each year. Researchers interviewed for the report agreed that the improvement has continued under President Donald Trump, but disputed the administration’s account of when it began.
The White House Office of National Drug Control Policy said deaths were down approximately 41.5% from their peak under the Biden administration and attributed the gains primarily to policies enacted under Trump over the previous 18 months. Its director, Sara Carter, credited tighter border security and efforts against drug-trafficking organizations.
CDC data show that overdose deaths began declining in 2023 and had fallen by roughly one-third by the time Joe Biden left office, according to the report. Vanda Felbab-Brown, a drug-policy expert at the Brookings Institution, said the decline had been steady since spring 2023. Nabarun Dasgupta, a researcher at the University of North Carolina at Chapel Hill, said some regions and demographic groups showed declines as early as 2021, with the fastest national decline occurring from early 2024 through spring 2025.
The researchers pointed to several possible contributors, including wider access to healthcare and the overdose-reversal medication naloxone, action against fentanyl trafficking, and a Biden-era agreement under which China agreed to restrict shipments of chemicals used to make fentanyl. They said the reasons for both the earlier surge in fentanyl deaths and the subsequent decline remain under study. Fentanyl remains the leading cause of drug deaths nationwide.
Asked about the earlier decline, Carter said Biden should not receive credit after overdose deaths reached record highs during his administration. She also said the Trump administration was working to dismantle drug-trafficking groups. Felbab-Brown disputed the suggestion that such organizations had been dismantled, saying they continued to operate and smuggle drugs.
Dasgupta raised a separate concern about whether the decline can be sustained as cuts to Medicaid take effect. The Congressional Budget Office estimated that the cuts could leave as many as 10 million Americans without health insurance; Dasgupta noted that Medicaid is the largest funder of addiction services in the United States.



